Gene-Disease Evidence Index

120-association public preview gene page

MT-ND6

mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6

Research use only. This page reports source-attributed evidence observed in the included release data. A gene symbol may appear in more than one rendered disease release. This is not medical advice, diagnosis, treatment guidance, patient risk prediction, clinical decision support, or clinical certainty. It covers only associations included in this release's fixed 120-association preview scope; absence from this page is not evidence of absence.
HGNC:7462 primary gene id
3 associations
3 evidence rows
3 releases

Release Packages

Methods and glossary
type2-diabetes-top120-v0.1.0-preview

release directory Git tag Data dictionary integrity.json ZIP archive

dilated-cardiomyopathy-top120-v0.1.0-preview

release directory Git tag Data dictionary integrity.json ZIP archive

huntington-disease-top120-v0.1.0-preview

release directory Git tag Data dictionary integrity.json ZIP archive

Identity

genes.json
Symbol
MT-ND6
Name
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
Aliases
none in primary release
Provenance
HGNC, Open Targets Platform

Type 2 diabetes mellitus

assoc:7462:0005148:07cd829f833a · huntington-disease-top120-v0.1.0-preview

association row
Status
observed unreviewed
Support tier
single source observed
Review
automatic checks only
Max source-reported score
0.616

Source Coverage

Supporting sources: Open Targets Platform

Silent sources: ClinVar

Single supporting source with queried-but-silent release source context.

  • Open Targets Platform: Source-attributed evidence signal; scores are not clinical truth or a combined confidence score. CC0 1.0; citation. Source freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026. Snapshot freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026; api-v4-graphql-2026-06-14-paper120, 120 records. Snapshot freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026; api-v4-graphql-2026-06-14-paper120, 120 records. Snapshot freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026; api-v4-graphql-2026-06-14-paper120, 120 records.

Evidence Rows evidence_rows.jsonl

Source Type Statement Open Targets score
Open Targets Platform OT:ENSG00000198695:MONDO_0005148 target disease association Open Targets reports MT-ND6 as associated with type 2 diabetes mellitus. 0.616

Open Targets score breakdown

Source-attributed signals reported by Open Targets for OT:ENSG00000198695:MONDO_0005148. Each value is Open Targets' own per-datatype or per-datasource score — not truth, clinical validity, or a combined confidence score. Labels such as clinical and clinical_precedence are Open Targets' own datatype and datasource names, not a clinical-use or clinical-validity signal for this association. The overall score is Open Targets' own aggregate over these datasources; because those datasources can overlap with evidence from other sources, the overall score is not an independent line of corroboration.

By datatype
  • clinical 0.999
  • literature 0.298
By datasource
  • clinical_precedence 0.999
  • europepmc 0.298

Caveats

  • Public-candidate draft; research-use only and not a clinical finding.
  • AI/referee review artifacts are advisory and do not replace human scientific review.
  • Open Targets scores are source-attributed evidence signals, not truth or clinical validity scores.
  • Open Targets target-disease association context is not diagnostic, treatment, or clinical decision-making guidance.
  • Single-source Open Targets evidence has not passed review gates.

Source names identify provenance only and do not imply endorsement by HGNC, MONDO, Open Targets, ClinVar, NCBI, or any upstream source.

Dilated cardiomyopathy

assoc:7462:0005021:5921a1d715b9 · huntington-disease-top120-v0.1.0-preview

association row
Status
observed unreviewed
Support tier
single source observed
Review
automatic checks only
Max source-reported score
0.763

Source Coverage

Supporting sources: Open Targets Platform

Silent sources: ClinVar

Single supporting source with queried-but-silent release source context.

  • Open Targets Platform: Source-attributed evidence signal; scores are not clinical truth or a combined confidence score. CC0 1.0; citation. Source freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026. Snapshot freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026; api-v4-graphql-2026-06-14-paper120, 120 records. Snapshot freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026; api-v4-graphql-2026-06-14-paper120, 120 records. Snapshot freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026; api-v4-graphql-2026-06-14-paper120, 120 records.

Evidence Rows evidence_rows.jsonl

Source Type Statement Open Targets score
Open Targets Platform OT:ENSG00000198695:EFO_0000407 target disease association Open Targets reports MT-ND6 as associated with dilated cardiomyopathy. 0.763

Open Targets score breakdown

Source-attributed signals reported by Open Targets for OT:ENSG00000198695:EFO_0000407. Each value is Open Targets' own per-datatype or per-datasource score — not truth, clinical validity, or a combined confidence score. Labels such as clinical and clinical_precedence are Open Targets' own datatype and datasource names, not a clinical-use or clinical-validity signal for this association. The overall score is Open Targets' own aggregate over these datasources; because those datasources can overlap with evidence from other sources, the overall score is not an independent line of corroboration.

By datatype
  • genetic_literature 0.827
  • genetic_association 0.816
  • literature 0.234
By datasource
  • genomics_england 0.907
  • eva 0.868
  • orphanet 0.608
  • uniprot_literature 0.608
  • gene2phenotype 0.608
  • europepmc 0.234

Caveats

  • Public-candidate draft; research-use only and not a clinical finding.
  • AI/referee review artifacts are advisory and do not replace human scientific review.
  • Open Targets scores are source-attributed evidence signals, not truth or clinical validity scores.
  • Open Targets target-disease association context is not diagnostic, treatment, or clinical decision-making guidance.
  • Single-source Open Targets evidence has not passed review gates.

Source names identify provenance only and do not imply endorsement by HGNC, MONDO, Open Targets, ClinVar, NCBI, or any upstream source.

Huntington disease

assoc:7462:0007739:ac9333d9b503 · huntington-disease-top120-v0.1.0-preview

association row
Status
observed unreviewed
Support tier
single source observed
Review
automatic checks only
Max source-reported score
0.262

Source Coverage

Supporting sources: Open Targets Platform

Silent sources: ClinVar

Single supporting source with queried-but-silent release source context.

  • Open Targets Platform: Source-attributed evidence signal; scores are not clinical truth or a combined confidence score. CC0 1.0; citation. Source freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026. Snapshot freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026; api-v4-graphql-2026-06-14-paper120, 120 records. Snapshot freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026; api-v4-graphql-2026-06-14-paper120, 120 records. Snapshot freshness: refresh recommended; assessed Jun 9, 2026; next review Jul 9, 2026; api-v4-graphql-2026-06-14-paper120, 120 records.

Evidence Rows evidence_rows.jsonl

Source Type Statement Open Targets score
Open Targets Platform OT:ENSG00000198695:MONDO_0007739 target disease association Open Targets reports MT-ND6 as associated with Huntington disease. 0.262

Open Targets score breakdown

Source-attributed signals reported by Open Targets for OT:ENSG00000198695:MONDO_0007739. Each value is Open Targets' own per-datatype or per-datasource score — not truth, clinical validity, or a combined confidence score. Labels such as clinical and clinical_precedence are Open Targets' own datatype and datasource names, not a clinical-use or clinical-validity signal for this association. The overall score is Open Targets' own aggregate over these datasources; because those datasources can overlap with evidence from other sources, the overall score is not an independent line of corroboration.

By datatype
  • clinical 0.426
  • literature 0.093
By datasource
  • clinical_precedence 0.426
  • europepmc 0.093

Caveats

  • Public-candidate draft; research-use only and not a clinical finding.
  • AI/referee review artifacts are advisory and do not replace human scientific review.
  • Open Targets scores are source-attributed evidence signals, not truth or clinical validity scores.
  • Open Targets target-disease association context is not diagnostic, treatment, or clinical decision-making guidance.
  • Single-source Open Targets evidence has not passed review gates.

Source names identify provenance only and do not imply endorsement by HGNC, MONDO, Open Targets, ClinVar, NCBI, or any upstream source.